Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $28.67 billion. The enterprise value is $29.79 billion.
Important Dates
The next confirmed earnings date is Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Feb 24, 2026 |
Share Statistics
Xylem has 243.14 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 243.14M |
| Shares Outstanding | 243.14M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | 94.08% |
| Float | 242.46M |
Valuation Ratios
The trailing PE ratio is 29.33 and the forward PE ratio is 21.14. Xylem's PEG ratio is 1.84.
| PE Ratio | 29.33 |
| Forward PE | 21.14 |
| PS Ratio | 3.15 |
| Forward PS | 3.09 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 61.37 |
| P/FCF Ratio | 30.88 |
| P/OCF Ratio | 21.78 |
| PEG Ratio | 1.84 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.58, with an EV/FCF ratio of 32.10.
| EV / Earnings | 30.37 |
| EV / Sales | 3.28 |
| EV / EBITDA | 15.58 |
| EV / EBIT | 22.20 |
| EV / FCF | 32.10 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.46 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | 2.09 |
| Interest Coverage | 53.68 |
Financial Efficiency
Return on equity (ROE) is 8.72% and return on invested capital (ROIC) is 8.60%.
| Return on Equity (ROE) | 8.72% |
| Return on Assets (ROA) | 5.01% |
| Return on Invested Capital (ROIC) | 8.60% |
| Return on Capital Employed (ROCE) | 9.45% |
| Weighted Average Cost of Capital (WACC) | 10.10% |
| Revenue Per Employee | $413,227 |
| Profits Per Employee | $44,591 |
| Employee Count | 22,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 5.54 |
Taxes
In the past 12 months, Xylem has paid $236.00 million in taxes.
| Income Tax | 236.00M |
| Effective Tax Rate | 19.54% |
Stock Price Statistics
The stock price has increased by +1.56% in the last 52 weeks. The beta is 1.17, so Xylem's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +1.56% |
| 50-Day Moving Average | 123.93 |
| 200-Day Moving Average | 136.92 |
| Relative Strength Index (RSI) | 38.42 |
| Average Volume (20 Days) | 2,520,538 |
Short Selling Information
The latest short interest is 5.27 million, so 2.17% of the outstanding shares have been sold short.
| Short Interest | 5.27M |
| Short Previous Month | 4.04M |
| Short % of Shares Out | 2.17% |
| Short % of Float | 2.17% |
| Short Ratio (days to cover) | 2.49 |
Income Statement
In the last 12 months, Xylem had revenue of $9.09 billion and earned $981.00 million in profits. Earnings per share was $4.02.
| Revenue | 9.09B |
| Gross Profit | 3.51B |
| Operating Income | 1.34B |
| Pretax Income | 1.21B |
| Net Income | 981.00M |
| EBITDA | 1.91B |
| EBIT | 1.34B |
| Earnings Per Share (EPS) | $4.02 |
Full Income StatementBalance Sheet
The company has $808.00 million in cash and $1.94 billion in debt, giving a net cash position of -$1.13 billion or -$4.65 per share.
| Cash & Cash Equivalents | 808.00M |
| Total Debt | 1.94B |
| Net Cash | -1.13B |
| Net Cash Per Share | -$4.65 |
| Equity (Book Value) | 11.23B |
| Book Value Per Share | 45.89 |
| Working Capital | 1.28B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.32 billion and capital expenditures -$388.00 million, giving a free cash flow of $928.00 million.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -388.00M |
| Depreciation & Amortization | 570.00M |
| Net Borrowing | -82.00M |
| Free Cash Flow | 928.00M |
| FCF Per Share | $3.82 |
Full Cash Flow StatementMargins
Gross margin is 38.61%, with operating and profit margins of 14.76% and 10.79%.
| Gross Margin | 38.61% |
| Operating Margin | 14.76% |
| Pretax Margin | 13.29% |
| Profit Margin | 10.79% |
| EBITDA Margin | 21.03% |
| EBIT Margin | 14.76% |
| FCF Margin | 10.21% |